Scientists in the Center for Applied Proteomics and Molecular Medicine are committed to a future where the individuality of a patient’s disease state determines tailored therapies and personalized management, and where disease is caught at the earliest, most treatable stage. To realize their vision, scientists engage in unique and creative collaborative relationships with health care organizations and corporate partners that combine scientific thinking and discoveries with clinical research and original clinical trials. New proteomic and nanotechnology-based tools and technologies that result from these relationships are accelerated into improved, early disease diagnosis, more effective disease treatment, and optimized, personalized patient care.